ACORN CAPITAL ADVISORS, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0002054410 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Aug 14, 2025

Total Value: $153M (100.0% shares, 0.0% debt)

Holdings (21)

CGON CG ONCOLOGY INC 19.2%

Value $29.42M Shares 1,131,501 Est. Cost $34.21 Unrealized -29.6%

URGN UROGEN PHARMA LTD 11.3%

Value $17.26M Shares 1,259,749 Est. Cost $11.97 Unrealized -19.9%

— Y-MABS THERAPEUTICS INC 10.1%

Value $15.42M Shares 3,418,995 Est. Cost $7.28 Unrealized —

PBYI PUMA BIOTECHNOLOGY INC 9.3%

Value $14.17M Shares 4,131,299 Est. Cost $2.92 Unrealized +9.2%

CADL CANDEL THERAPEUTICS INC 8.5%

Value $13.06M Shares 2,580,517 Est. Cost $5.97 Unrealized -13.8%

TRVI TREVI THERAPEUTICS INC 7.7%

Value $11.73M Shares 2,144,844 Est. Cost $3.31 Unrealized +88.2%

TERN TERNS PHARMACEUTICALS INC 4.8%

Value $7.353M Shares 1,971,264 Est. Cost $6.77 Unrealized -53.9%

OKUR ONKURE THERAPEUTICS INC 4.4%

Value $6.787M Shares 2,839,674 Est. Cost $8.97 Unrealized -70.8%

HELP CYBIN INC 4.0%

Value $6.162M Shares 734,394 Est. Cost $10.16 Unrealized -28.4%

BCAX BICARA THERAPEUTICS 3.9%

Value $5.977M Shares 643,382 Est. Cost $20.81 Unrealized -42.7%

TARA PROTARA THERAPEUTICS INC 3.5%

Value $5.309M Shares 1,752,115 Est. Cost $3.29 Unrealized +4.9%

CRDF CARDIF ONCOLOGY INC 2.9%

Value $4.438M Shares 1,408,767 Est. Cost $3.13 Unrealized -2.4%

AURA AURA BIOSCIENCES INC 2.4%

Value $3.729M Shares 595,744 Est. Cost $7.57 Unrealized -22.7%

VSTM VERASTEM INC 2.1%

Value $3.235M Shares 779,498 Est. Cost $3.94 Unrealized +59.1%

WHWK WHITEHAWK THERAPEUTICS INC 1.4%

Value $2.131M Shares 1,139,363 Est. Cost $2.27 Unrealized -23.2%

BCAB BIOATLA INC 1.3%

Value $1.915M Shares 4,835,111 Est. Cost $1.47 Unrealized -72.4%

— MURAL ONCOLOGY PLC 1.1%

Value $1.615M Shares 653,779 Est. Cost $3.22 Unrealized —

VYNE VYNE THERAPEUTICS INC 0.8%

Value $1.215M Shares 736,572 Est. Cost $2.55 Unrealized -49.1%

QTTB Q32 BIO INC. 0.8%

Value $1.197M Shares 803,425 Est. Cost $31.58 Unrealized -94.6%

ACRV ACRIVON THERAPEUTICS INC 0.3%

Value $482K Shares 405,237 Est. Cost $7.27 Unrealized -81.1%

— X4 PHARMACEUTICALS INC 0.2%

Value $292K Shares 153,730 Est. Cost $0.73 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	1,131,501	$29.42M	19.2%	$34.21	-29.6%	COM	156944100
URGN	UROGEN PHARMA LTD	1,259,749	$17.26M	11.3%	$11.97	-19.9%	COM	M96088105
—	Y-MABS THERAPEUTICS INC	3,418,995	$15.42M	10.1%	$7.28	—	COM	984241109
PBYI	PUMA BIOTECHNOLOGY INC	4,131,299	$14.17M	9.3%	$2.92	+9.2%	COM	74587V107
CADL	CANDEL THERAPEUTICS INC	2,580,517	$13.06M	8.5%	$5.97	-13.8%	COM	137404109
TRVI	TREVI THERAPEUTICS INC	2,144,844	$11.73M	7.7%	$3.31	+88.2%	COM	89532M101
TERN	TERNS PHARMACEUTICALS INC	1,971,264	$7.353M	4.8%	$6.77	-53.9%	COM	880881107
OKUR	ONKURE THERAPEUTICS INC	2,839,674	$6.787M	4.4%	$8.97	-70.8%	CLASS A COM	68277Q105
HELP	CYBIN INC	734,394	$6.162M	4.0%	$10.16	-28.4%	COM NEW	23256X407
BCAX	BICARA THERAPEUTICS	643,382	$5.977M	3.9%	$20.81	-42.7%	COM	055477103
TARA	PROTARA THERAPEUTICS INC	1,752,115	$5.309M	3.5%	$3.29	+4.9%	COM STK	74365U107
CRDF	CARDIF ONCOLOGY INC	1,408,767	$4.438M	2.9%	$3.13	-2.4%	COM	14147L108
AURA	AURA BIOSCIENCES INC	595,744	$3.729M	2.4%	$7.57	-22.7%	COM	05153U107
VSTM	VERASTEM INC	779,498	$3.235M	2.1%	$3.94	+59.1%	COM	92337C203
WHWK	WHITEHAWK THERAPEUTICS INC	1,139,363	$2.131M	1.4%	$2.27	-23.2%	COM	00032Q104
BCAB	BIOATLA INC	4,835,111	$1.915M	1.3%	$1.47	-72.4%	COM	09077B104
—	MURAL ONCOLOGY PLC	653,779	$1.615M	1.1%	$3.22	—	COM	G63365103
VYNE	VYNE THERAPEUTICS INC	736,572	$1.215M	0.8%	$2.55	-49.1%	COM	92941V308
QTTB	Q32 BIO INC.	803,425	$1.197M	0.8%	$31.58	-94.6%	COM	746964105
ACRV	ACRIVON THERAPEUTICS INC	405,237	$482K	0.3%	$7.27	-81.1%	COMMON STOCK	004890109
—	X4 PHARMACEUTICALS INC	153,730	$292K	0.2%	$0.73	—	COM	98420X103